NCT03479463
Terminated
Not Applicable
A Matched Case Clinical Registry - Efficacy of AmnioFix in the Prevention of Post-Operative Salivary Leaks Following Head and Neck Surgery
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Larynx Cancer
- Sponsor
- MiMedx Group, Inc.
- Enrollment
- 8
- Locations
- 1
- Primary Endpoint
- Incidence of Pharayngocutaneous Fistula Development (PCF)
- Status
- Terminated
- Last Updated
- 5 years ago
Overview
Brief Summary
This trial aims to determine if intra-operative use of human dehydrated amnion chorion allograft improves post-operative patient healing outcomes.
Detailed Description
This study is to determine if intra-operative use of Amnio-Fix improves post-operative patient healing outcomes after laryngectomy and/or pharyngectomy.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subject is scheduled to undergo laryngectomy and/or pharyngectomy procedure due to oncological indication
- •Subject is age 18 or older
- •Subject is willing and able to provide informed consent and participate in all procedures and follow-up evaluations necessary to complete the study
Exclusion Criteria
- •Subjects currently enrolled in or planning to enroll in another clinical trial
- •Subjects with a known history of poor compliance with medical treatments
- •Subjects that are using or have used an investigational drug, device, or biologic within the 12 weeks prior to treatment
- •Subjects that have any significant medical condition(s) that, in the opinion of the Investigator, would interfere with protocol evaluation and participation
- •Subject has undergone previous pharyngeal reconstructive surgery
- •Pregnancy at enrollment or within last 6 months, women who are breastfeeding, or women of childbearing potential who are planning to become pregnant during the time of the study OR are unwilling/unable to use acceptable methods of contraception (birth control pills, barriers, or abstinence)
Outcomes
Primary Outcomes
Incidence of Pharayngocutaneous Fistula Development (PCF)
Time Frame: 60 days
Incidence of PCF developement necessitating intervention within the 60 day time point.
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Comparison of Dehydrated Human Amnion-Chorion and Type 1 Bovine Collagen Membranes for Guided Bone RegenerationRidge DeficiencyNCT03290638Samer Faraj43
Active, not recruiting
Phase 2
Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical ProstatectomyProstate CancerErectile Dysfunction Following Radical ProstatectomyNCT05842057University of Miami118
Completed
Not Applicable
Case Series of Weekly Applications of dHACM in Treatment of Pressure UlcersPressure UlcerNCT02861560MiMedx Group, Inc.10
Recruiting
Not Applicable
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot UlcersDiabetic FootUlcer FootFoot UlcerDiabetic Foot UlcerNCT06550596Axolotl Biologix100
Completed
Not Applicable
Use of dHACM in the Treatment of Venous Leg UlcersLeg UlcerNCT02011503MiMedx Group, Inc.128